Lyna Z Schieber
Overview
Explore the profile of Lyna Z Schieber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ragan-Burnett K, Curtis C, Schmit K, Mikosz C, Schieber L, Guy Jr G, et al.
AJPM Focus
. 2024 Sep;
3(6):100269.
PMID: 39345913
Introduction: In 2016, the Centers for Disease Control and Prevention released the Guideline for Prescribing Opioids for Chronic Pain (2016 Centers for Disease Control and Prevention Guideline) to improve opioid...
2.
Rikard S, Strahan A, Schieber L, Guy Jr G
JAMA
. 2024 Jun;
332(2):165-167.
PMID: 38869869
No abstract available.
3.
Schieber L, Rikard S, Strahan A, Losby J, Guy Jr G
Am J Prev Med
. 2024 Feb;
66(6):1071-1074.
PMID: 38307158
No abstract available.
4.
Schieber L, Lopes-Cardozo B, Guy Jr G
JAMA Psychiatry
. 2023 Jul;
80(9):968-969.
PMID: 37405793
No abstract available.
5.
Schieber L, Dunphy C, Schieber R, Lopes-Cardozo B, Moonesinghe R, Guy Jr G
JAMA Psychiatry
. 2023 Feb;
80(4):331-341.
PMID: 36790774
Importance: During the COVID-19 pandemic, US emergency department (ED) visits for psychiatric disorders (PDs) and drug overdoses increased. Psychiatric disorders and substance use disorders (SUDs) independently increased the risk of...
6.
Montgomery M, Hong K, Clarke K, Williams S, Fukunaga R, Fields V, et al.
JAMA Netw Open
. 2022 Jan;
5(1):e2143407.
PMID: 35024835
Importance: People experiencing incarceration (PEI) and people experiencing homelessness (PEH) have an increased risk of COVID-19 exposure from congregate living, but data on their hospitalization course compared with that of...
7.
Kompaniyets L, Pennington A, Goodman A, Rosenblum H, Belay B, Ko J, et al.
Prev Chronic Dis
. 2021 Jul;
18:E66.
PMID: 34197283
Introduction: Severe COVID-19 illness in adults has been linked to underlying medical conditions. This study identified frequent underlying conditions and their attributable risk of severe COVID-19 illness. Methods: We used...
8.
Kompaniyets L, Agathis N, Nelson J, Preston L, Ko J, Belay B, et al.
JAMA Netw Open
. 2021 Jun;
4(6):e2111182.
PMID: 34097050
Importance: Information on underlying conditions and severe COVID-19 illness among children is limited. Objective: To examine the risk of severe COVID-19 illness among children associated with underlying medical conditions and...
9.
Pennington A, Kompaniyets L, Summers A, Danielson M, Goodman A, Chevinsky J, et al.
Open Forum Infect Dis
. 2021 Feb;
8(2):ofaa638.
PMID: 33553477
Background: Older adults and people from certain racial and ethnic groups are disproportionately represented in coronavirus disease 2019 (COVID-19) hospitalizations and deaths. Methods: Using data from the Premier Healthcare Database...
10.
Bull-Otterson L, Gray E, Budnitz D, Strosnider H, Schieber L, Courtney J, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Sep;
69(35):1210-1215.
PMID: 32881845
Hydroxychloroquine and chloroquine, primarily used to treat autoimmune diseases and to prevent and treat malaria, received national attention in early March 2020, as potential treatment and prophylaxis for coronavirus disease...